Gene Therapy Market size is expected to grow from US$ 6.21 Bn. in 2021 to US$ 44.51 Bn. by 2029, growing at a CAGR of 27.9% through 2022 to 2029.
Gene Therapy Market overview
Maximize Market Research provides a brief description of Gene Therapy, provides the latest snapshots of the market, and best understands its features. The report covers analysed insights in view of the Gene Therapy Market along with its ever-changing patterns, industry environment, and all dominant aspects of the market. The research methodology has been applied to analyse the Gene Therapy Market and these findings have been logically mentioned in the report.
Request for sample pages : https://www.maximizemarketresearch.com/request-sample/85074
Gene Therapy Market scope
The report provides in-depth analysis of the Gene Therapy Market which is equipped with key findings that act as a guide for the stakeholders and investors in the Gene Therapy market. The report uses a bottom-up approach to understand Gene Therapy market estimations which are validated by various segments. A detailed study is conducted on the drivers, challenges, restraints to the Gene Therapy market and opportunities prevailing for the Gene Therapy Market.
SWOT, and Porter’s Five Force analysis tools were used for research that combined qualitative and quantitative methods of research from the Gene Therapy. Primary research was used to validate the findings from the secondary research. Thereby the report acts as a guide for investors, and market followers of the Gene Therapy Market.
Segmentation
Acute Lymphoblastic Leukaemia (ALL), Inherited Retinal Disease, Large B-cell Lymphoma, ADA-SCID, Melanoma (lesions), Beta-Thalassemia Major/SCD, Head & Neck Squamous Cell Carcinoma, Peripheral Arterial Disease, Spinal Muscular Atrophy (SMA), and Others are the different indications that the market is divided into. By holding a 41% market share in 2021, the Spinal Muscular Atrophy (SMA) sector is anticipated to maintain its dominance through the year 2029. SMA, one of the most common fatal genetic childhood diseases, affects the muscles. As a gene treatment, Zolgensma (AVXS-101) has proven to be effective in curing SMA and changing the disease’s phenotype. In May 2021, the FDA approved Zolgensma, a medication developed by Novartis to address the fundamental cause of SMA.
The market is divided into Lentivirus, AAV, Retrovirus & gamma Retrovirus, Modified Herpes Simplex Virus, Adenovirus, and Non-viral Plasmid Vector based on the type of vector used. The AAV segment is anticipated to expand quickly between 2022 and 2029, with a CAGR of 27.9%. In 2021, the AAV sector had the most market share (43%). There will be a huge demand for AAV in the next years because its application has grown dramatically in recent years across several therapeutic disciplines. Their established non-pathogenicity is one of the most important factors influencing their adoption. AAV viral vector-based gene therapy research and development is being conducted by a number of firms, including Dimension Therapeutics, AGTC, Spark Therapeutics, Sangamo Biosciences, Biogen, and AveXis.
Get more Report Details: https://www.maximizemarketresearch.com/market-report/global-gene-therapy-market/85074/
Key Players
• REGENXBIO, Inc.
• Bayer
• Oxford BioMedica plc
• Dimension Therapeutics, Inc.
• Bristol-Myers Squibb Company
• SANOFI
• Applied Genetic Technologies Corp
• F. Hoffmann-La Roche Ltd.
• Bluebird Bio, Inc.
• Novartis AG
• Taxus Cardium Pharmaceuticals Group, Inc. (Gene Biotherapeutics)
• UniQure N.V.
• Shire Plc;
• Cellectis S.A.
• Sangamo Therapeutics, Inc.
• Orchard Therapeutics
• Gilead Lifesciences, Inc.
• Benitec Biopharma Ltd.
• Sibiono GeneTech Co., Ltd.
• Shanghai Sunway Biotech Co., Ltd
• Gensight Biologics S.A.
Regional Analysis
The research report gives a detailed analysis of the Gene Therapy market that is divided into regions. The report includes an evaluation of regional market participants operating in the market, as well as findings pertinent to the target Gene Therapy market. On a regional and country-by-country basis, the study evaluates the market in North America, Latin America, Europe, Asia Pacific (APAC), Africa, and the Middle East. Each region & market is thoroughly researched, allowing for the discovery of regional market trends, constraints, and growth potential.
Get More Information On the Gene Therapy Market Report: https://www.maximizemarketresearch.com/request-sample/85074
Key Questions answered in the Gene Therapy Market Report are:
- What is Gene Therapy?
- What was the Gene Therapy market size in 2021?
- What is the expected Gene Therapy market size by 2029?
- What is the growth rate of the Gene Therapy Market?
- Which are the factors expected to drive the Gene Therapy market growth?
- Which segment dominated the Gene Therapy market growth?
- What is the demand pattern for the Gene Therapy market?
- Which region held the largest share in the Gene Therapy market?
- Who are the key players in the Gene Therapy market?
Key offerings:
- Market Share, Size, and Forecast by Revenue|2022-2029
- Market Dynamics- Growth drivers, Restraints, Investment Opportunities, and key trends
- Market Segmentation: A detailed analysis by Gene Therapy
- Landscape- Leading key players and other prominent key players.
About Maximize Market Research:
Maximize Market Research is a multifaceted market research and consulting company with professionals from several industries. Some of the industries we cover include science and engineering, electronic components, industrial equipment, technology, and communication, cars, and automobiles, chemical products and substances, general merchandise, beverages, personal care, and automated systems. To mention a few, we provide market-verified industry estimations, technical trend analysis, crucial market research, strategic advice, competition analysis, production and demand analysis, and client impact studies.
Contact Maximize Market Research:
3rd Floor, Navale IT Park, Phase 2
Pune Banglore Highway, Narhe,
Pune, Maharashtra 411041, India
+91 96071 95908, +91 9607365656
